Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.9 EUR | -3.25% | +4.20% | +106.94% |
May. 09 | Medincell: share price rises on resumption of trading | CF |
May. 08 | CAC40: remains in green in a neglected market | CF |
Sales 2024 * | 13.96M 15.03M | Sales 2025 * | 41.8M 45.02M | Capitalization | 428M 461M |
---|---|---|---|---|---|
Net income 2024 * | -23M -24.77M | Net income 2025 * | 1M 1.08M | EV / Sales 2024 * | 34.2 x |
Net Debt 2024 * | 48.73M 52.48M | Net Debt 2025 * | 58.83M 63.36M | EV / Sales 2025 * | 11.7 x |
P/E ratio 2024 * |
-16.3
x | P/E ratio 2025 * |
-279
x | Employees | 138 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.98% |
Latest transcript on MedinCell S.A.
1 day | -3.25% | ||
1 week | +4.20% | ||
Current month | +3.76% | ||
1 month | +60.73% | ||
3 months | +71.07% | ||
6 months | +148.75% | ||
Current year | +106.94% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 60 | 03-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 50 | 23-08-31 |
Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sabri Markabi
BRD | Director/Board Member | - | 17-07-04 |
Tone Kvåle
BRD | Director/Board Member | 55 | 22-06-12 |
Virginie Lleu
BRD | Director/Board Member | - | 16-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 14.9 | -3.25% | 166,941 |
24-05-09 | 15.4 | +3.77% | 491,265 |
24-05-08 | 14.84 | 0.00% | 0 |
24-05-07 | 14.84 | +1.50% | 73,679 |
24-05-06 | 14.62 | +2.24% | 89,719 |
Real-time Euronext Paris, May 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+106.94% | 461M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- MEDCL Stock